Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Verme

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Hepatology (Baltimore, Md.)|November 1, 1984
HLA-DR antigens in HBsAg-positive chronic active liver disease with and without associated delta infectionB Forzani, G C Actis, G Verme, et al.
Journal of Hepatology|February 1, 1994
Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active doseM R Torrani Cerenzia, L Fiume, C Busi, et al.
The Italian Journal of Gastroenterology|July 1, 1996
Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trialG R Corazza, F Biagi, O Albano, et al.
Lancet (London, England)|October 30, 1982
Influence of delta infection on severity of hepatitis BA Smedile, P Farci, G Verme, et al.
Gastroenterology|September 1, 1972
Occurrence of Australia antigen in chronic hepatitis in ItalyP Bianchi, C B Porro, M Coltorti, et al.
Hepatology (Baltimore, Md.)|April 1, 1996
Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effectsM Torrani Cerenzia, L Fiume, W De Bernardi Venon, et al.
Journal of Hepatology|July 1, 1997
Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trialG Saracco, E Borghesio, P Mesina, et al.
Journal of Viral Hepatitis|November 1, 1996
Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease? [corrected]P Colombatto, A Randone, G Civitico, et al.
Journal of Viral Hepatitis|January 1, 1997
A new hepatitis C virus-like flavivirus in patients with cryptogenic liver disease associated with elevated GGT and alkaline phosphatase serum levelsP Colombatto, A Randone, G Civitico, et al.
The Italian Journal of Gastroenterology|September 1, 1996
Effect of patient characteristics on hospital costs for cirrhosis: implications for the disease-related group (DRG) reimbursement systemF Rosina, P Alaria, S Castelli, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Hepatology (Baltimore, Md.)|November 1, 1984
HLA-DR antigens in HBsAg-positive chronic active liver disease with and without associated delta infectionB Forzani, G C Actis, G Verme, et al.
Journal of Hepatology|February 1, 1994
Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active doseM R Torrani Cerenzia, L Fiume, C Busi, et al.
The Italian Journal of Gastroenterology|July 1, 1996
Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trialG R Corazza, F Biagi, O Albano, et al.
Lancet (London, England)|October 30, 1982
Influence of delta infection on severity of hepatitis BA Smedile, P Farci, G Verme, et al.
Gastroenterology|September 1, 1972
Occurrence of Australia antigen in chronic hepatitis in ItalyP Bianchi, C B Porro, M Coltorti, et al.
Hepatology (Baltimore, Md.)|April 1, 1996
Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effectsM Torrani Cerenzia, L Fiume, W De Bernardi Venon, et al.
Journal of Hepatology|July 1, 1997
Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trialG Saracco, E Borghesio, P Mesina, et al.
Journal of Viral Hepatitis|November 1, 1996
Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease? [corrected]P Colombatto, A Randone, G Civitico, et al.
Journal of Viral Hepatitis|January 1, 1997
A new hepatitis C virus-like flavivirus in patients with cryptogenic liver disease associated with elevated GGT and alkaline phosphatase serum levelsP Colombatto, A Randone, G Civitico, et al.
The Italian Journal of Gastroenterology|September 1, 1996
Effect of patient characteristics on hospital costs for cirrhosis: implications for the disease-related group (DRG) reimbursement systemF Rosina, P Alaria, S Castelli, et al.
Pageof 15